MEF2C gene variations are associated with ADHD in the Chinese Han population: a case-control study

J Neural Transm (Vienna). 2022 Apr;129(4):431-439. doi: 10.1007/s00702-022-02490-9. Epub 2022 Mar 31.

Abstract

Myocyte enhancer factor 2C (MEF2C) is associated with hyperactivity and might be a novel risk gene for susceptibility to attention deficit hyperactivity disorder (ADHD). Therefore, this study aimed to explore the association between MEF2C genetic variants and ADHD in the Chinese Han population. A total of 215 patients with ADHD and 233 controls were recruited for this study. The Swanson, Nolan, and Pelham version IV questionnaire was used to evaluate the clinical features of ADHD. In silico analysis was used to annotate the biological functions of the promising single nucleotide polymorphisms. Our findings indicated that MEF2C rs587490 was significantly associated with ADHD in the multiplicative model (OR = 0.640, p = 0.002). Participants with the rs587490 TT allele exhibited less hyperactivity/impulsivity than those with the rs587490 CC allele. Furthermore, the expression quantitative trait loci analysis suggested that rs587490 could regulate the gene expression of MEF2C in the hippocampus, putamen, thalamus, and frontal white matter. Our study concluded that the MEF2C rs587490 T allele is significantly associated with a reduced risk of ADHD in the Chinese Han population, which provides new insight into the genetic etiology of ADHD.

Keywords: Attention–deficit/hyperactivity disorder; Gene variations; Myocyte enhancer factor 2C; Single nuclear polymorphisms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asian People / genetics
  • Attention Deficit Disorder with Hyperactivity* / epidemiology
  • Attention Deficit Disorder with Hyperactivity* / genetics
  • Case-Control Studies
  • China
  • Genotype
  • Humans
  • MEF2 Transcription Factors / genetics
  • Polymorphism, Single Nucleotide

Substances

  • MEF2 Transcription Factors
  • MEF2C protein, human